PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Palbociclib
Presentation Product Chemical substance Chapter Items dispensed
Ibrance 100mg capsules
0801050CBBBABAB
Ibrance Palbociclib Malignant Disease and Immunosuppression No data available
Ibrance 100mg tablets
0801050CBBBADAD
Ibrance Palbociclib Malignant Disease and Immunosuppression No data available
Ibrance 125mg capsules
0801050CBBBACAC
Ibrance Palbociclib Malignant Disease and Immunosuppression No data available
Ibrance 125mg tablets
0801050CBBBAEAE
Ibrance Palbociclib Malignant Disease and Immunosuppression No data available
Ibrance 75mg capsules
0801050CBBBAAAA
Ibrance Palbociclib Malignant Disease and Immunosuppression No data available
Ibrance 75mg tablets
0801050CBBBAFAF
Ibrance Palbociclib Malignant Disease and Immunosuppression No data available
Palbociclib 100mg capsules
0801050CBAAABAB
Palbociclib Palbociclib Malignant Disease and Immunosuppression No data available
Palbociclib 100mg tablets
0801050CBAAADAD
Palbociclib Palbociclib Malignant Disease and Immunosuppression No data available
Palbociclib 125mg capsules
0801050CBAAACAC
Palbociclib Palbociclib Malignant Disease and Immunosuppression No data available
Palbociclib 125mg tablets
0801050CBAAAEAE
Palbociclib Palbociclib Malignant Disease and Immunosuppression No data available
Palbociclib 75mg capsules
0801050CBAAAAAA
Palbociclib Palbociclib Malignant Disease and Immunosuppression No data available
Palbociclib 75mg tablets
0801050CBAAAFAF
Palbociclib Palbociclib Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.